Chicago, 2018-04-14 - NBE-Therapeutics attended the 2018 AACR conference in Chicago

NBE-Therapeutics' CEO Ulf Grawunder presented at this year's AACR conference in Chicago, IL, in mid April

The American Association for Cancer Research (AACR) has selected NBE-Therapeutics abstract submission for a poster presentation at this year's annual AACR congress, which took place from April 14-18, 2018 at McCormick Place South, in Chicago, IL, U.S. NBE-Therapeutics poster is entitled "Antibody drug conjugates with anthracycline payload induce tumor-selective anti-tumor immunity and exhibit a favorable safety profile in cynomogus monkey toxicology studies" and was presented to the public on Sunday, April 15 from 1-5 p.m., in poster section 35, poster board number 737. NBE-Therapeutics' CEO, Ulf Grawunder, was present during the time of the poster session for any discussions of the presented results. The link to the 2018 annual AACR congress is: http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136#.Wp0kGRPwaUY

 

 

All news